Obesity medications in development
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2020.1705277
Abstract: ABSTRACT Introduction: Obesity is compounded by a neurobiology that is resistant to weight loss. Therefore, the development of pharmacotherapies to address the pathology underlying the dysregulation of energy homeostasis is critical. Areas covered: This review… read more here.
Keywords: anti obesity; obesity medications; expert opinion; obesity ... See more keywords
A narrative review of anti-obesity medications for obese patients with osteoarthritis
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2104636
Abstract: ABSTRACT Introduction The prevalence of both obesity and osteoarthritis (OA) is increasing worldwide (twindemic), and the association between the two chronic diseases is also well established. Areas covered In this narrative review, we will briefly… read more here.
Keywords: narrative review; anti obesity; obesity medications; obesity ... See more keywords
Potential contributors to variation in weight‐loss response to liraglutide
Sign Up to like & getrecommendations! Published in 2023 at "Obesity Reviews"
DOI: 10.1111/obr.13568
Abstract: Obesity treatment requires a chronic state of negative energy balance. Obesity medications can help with this, increasing long‐term dietary compliance by promoting satiety or reducing hunger. However, efficacy and safety of obesity medications vary for… read more here.
Keywords: loss; loss response; obesity medications; weight loss ... See more keywords